The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT01251289
First received: November 30, 2010
Last updated: June 8, 2012
Last verified: December 2009
  Purpose
A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

Condition
Group B Streptococcus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

Further study details as provided by St. Michael's Hospital, Toronto:

Enrollment: 628
Study Start Date: December 2009
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Detailed Description:
This is a retrospective chart review of the prevalence of Group B Streptococcus (GBS) positive patients
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Group B streptococcus positive pregnant women
Criteria

Inclusion Criteria:

  • GBS positive pregnant women

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01251289

Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark Yudin, MD St. Michael's Hospital, Toronto
  More Information

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT01251289     History of Changes
Other Study ID Numbers: REB 09-072 
Study First Received: November 30, 2010
Last Updated: June 8, 2012
Health Authority: St. Michael's Hospital:

ClinicalTrials.gov processed this record on August 23, 2016